Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'Improving ethnic diversity in workplace is a never-ending journey'

The journey on building inclusive teams and increasing ethnic diversity and representation at all levels is never ending, said Sanjay Bhandari, chair at Kick It Out.

“I think you can set the direction but it's quite difficult to set the destination with these things,” Bhandari, who is part of the government-sponsored Parker review into the ethnic diversity of UK boards said during a panel discussion on Inclusive Leadership held as part of the Pharmacy Business Diversity Conference on Thursday (December 9).


He said the aim of the review was to fix a destination like a milestone, it's not the ultimate destination.

Bhandari highlighted that “most organizations have not even started and so a good way of getting started was by the end of 2021 to have at least one British born director of color on your board for the FTSE 100 (companies).”

The idea of the review is to “focus on that pathway and filling the hole in the doughnut,” Bhandari said.

There is a need to modernize the leadership style to meet the diversity and inclusion goals, he added.

“I think it's about asking and not assuming it's about demonstrating some empathy. And it's about converting those behaviors into tangible activities.”

The session was moderated by the conference chair BBC presenter Clive Myrie, joined by Ravi Chand CBE, director, Places for Growth and Beyond at the Cabinet Office and Antonio Bebba, regional operations lead for Pfizer’s Diversity, Equity & Inclusion Council Europe (DICE).

Approving the recommendations of the Parker review, Chand said it's really important for people at the top to “set the tone and expectation.”

He added there is a need to change the system in terms of hiring.

“You have to change the system. Otherwise you can get very enlightened individuals right across the organisation, operating the very machinery that still discriminates and creates less favourable outcomes for people of colour”.

Bebba added that leadership is essential to bring key changes in the company’s culture.

This ideology drove Pfizer to add equity as its one of the company’s values, in 2019.

He said: “Our final goal is to be sure that all the colleagues that are working at Pfizer from when they enter in the company until when they leave, they experience inclusion in all the way around a 360 degree.

“Working with intersectionality allows you to make sure that everyone is included in the conversation.

After achieving a balanced representation of all communities in the company, Pfizer aims to ensure that they feel included in value, in the decision making process and be an integral part of the current change, Bebba added.

More For You

Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less